Carl Zeiss Meditec Appoints Steven C. Schallhorn as Chief Medical Officer
Friday, October 14 2016 | 00 h 00 min | Appointments, Press Release
JENA, Germany/DUBLIN, California, USA
Carl Zeiss Meditec announces the appointment of Steven C. Schallhorn, MD as Chief Medical Officer for Global Ophthalmic Devices consisting of Refractive Lasers, Surgical Ophthalmology and Ophthalmic Diagnostics. As the leading medical advisor for the organization, Dr. Schallhorn will serve on the Executive Leadership Team providing strategic direction for the business and medical guidance on the clinical use of ZEISS’ broad portfolio of ophthalmic diagnostic and surgical technologies. Dr. Schallhorn will collaborate with Key Opinion Leaders (KOLs) and academic institutions on research initiatives and the development of best practices for improving clinical outcomes, practice efficiency and cost effectiveness.
Dr. Schallhorn has led many clinical studies focused on the safety and effectiveness of eye surgery as well as the quality of vision. He has presented to the US FDA numerous times and was instrumental in the approval of many ophthalmic devices and the NASA approval of LASIK.
Steven C. Schallhorn, MD is board certified, licensed ophthalmologist in private practice in San Diego, California, a Clinical Professor of Ophthalmology at the University of California, San Francisco and the Chief Medical Director for Optical Express.
After graduating from Colorado State University, Captain Schallhorn served in US Navy as an F-14 aviator and a Navy Fighter Weapons School instructor (TOPGUN). He completed his medical degree at the Uniformed Services University of the Health Sciences, ophthalmology residency at the Naval Medical Center San Diego, and cornea fellowship at the Doheny Eye Institute, University of Southern California. He founded the Department of Defense refractive surgery program and directed the Naval Medical Center San Diego.
Dr. Schallhorn has served on the Executive Committee for the American Academy of Ophthalmology International Society of Refractive Surgeons, Chairman of the AAO ISRS Program Committee, Chairman of the AAO Refractive Ophthalmic Technology Assessment Committee and Editor for the AAO ONE Program. Dr. Schallhorn has been a visiting professor of medicine at Harvard, USC, UCSF and Baylor. Dr. Schallhorn has received the ASCRS Binkhorst award, the AAO Lans award and will be awarded the ISRS 2016 Casebeer Award for outstanding contributions to refractive surgery.
